Will Lanza finally rejoin Dr. West to form ReCyte? They both share multiple patents that will allow them to ipo ReCyte with therapeutic blood/stem cell therapy....stay tuned!
Will be huge when mainstream investors discover BTX.
Scooping up more shares in current dip before Pan-C products announced is a smart idea!
I think Dr. West will move onto ReCyte as CEO, a company that will offer what West has been after his whole life...gerontology.
Cancer is just starting to be understood. Biotimes OncoCyte will have the first next-gen diagnostic product on the market by end of this year.btw, big announcement concerning second BTX subsidiary IPO.